StockData
Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc. (MIRM) shareholders

MIRMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30
$91.95+0.37 (+0.40%)

Close on Nov 17, 2026Market cap $5.97BP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
100.0%
71M of 65M shares
Institutional holders
327
62 new, 43 sold out
Net institutional buying
10M
In Q2 2026
Insider trades, 12 months
1 buys · 63 sales
Net sold $36.52M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Janus Henderson Group PLC6,065,30811.80%13G (passive) amendmentDec 31, 2025
JANUS HENDERSON GROUP Ltd.5,909,1849.70%13G (passive) amendmentJun 30, 2026
Patrick J. Heron
Joint filing with James N. Topper (6.70%), Frazier Life Sciences IX, L.P. (5.90%) and 2 more
4,108,4046.80%13D (active) amendmentJan 23, 2026
Abigail P. Johnson
Joint filing with FMR LLC (6.20%)
3,777,8516.20%13G (passive)Jun 30, 2026
James N. Topper
Joint filing with Patrick J. Heron (7.60%), Fhmls Ix, L.P. (7.10%) and 5 more
3,735,2207.40%13D (active) amendmentNov 1, 2025
BlackRock, Inc.3,465,5595.70%13G (passive) amendmentMar 31, 2026
Finny Kuruvilla, M.D., Ph. D.
Joint filing with Eventide Asset Management, LLC (5.43%), Robin C. John (5.43%)
2,606,9385.43%13G (passive) amendmentDec 31, 2024

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of MIRMValueChange% of portfolio
Frazier Life Sciences Management, L.P.7,679,68411.83%$899.06M–19.58%
Jupiter Topco LLC5,909,1849.10%$691.67MNew0.28%
BlackRock, Inc.4,390,0636.76%$513.94M+543,5330.01%
FMR LLC3,670,3145.65%$429.68M+1,704,9390.02%
Price T Rowe Associates Inc /Md/2,655,6074.09%$310.89M+938,1860.03%
Vanguard Portfolio Management LLC2,377,0193.66%$278.28M+944,9360.01%
Vanguard Capital Management LLC2,254,1093.47%$263.89M−160,6670.01%
State Street Corp2,170,6893.34%$254.12M+226,4080.01%
William Blair Investment Management, LLC1,404,7412.16%$164.45M+1,069,0720.49%
Geode Capital Management, LLC1,393,9082.15%$163.21M+133,9050.01%
Invesco Ltd.1,364,0842.10%$159.69M+1,078,8480.01%
Wellington Management Group Llp1,309,9872.02%$153.36M−24,8220.03%
Eventide Asset Management, LLC1,248,3891.92%$146.20M−160,4821.95%
Tang Capital Management LLC1,236,0271.90%$144.70M–6.57%
Capital World Investors1,153,4801.78%$135.04M+429,0650.02%
Franklin Resources Inc1,152,7701.78%$134.95M+437,9660.03%
Novo Holdings A/S1,125,0001.73%$131.70M−200,0007.65%
TCG Crossover Management, LLC1,062,0491.64%$124.33M–2.99%
Bvf Inc/Il1,056,0271.63%$123.63M−528,7003.16%
Polar Capital Holdings Plc845,5241.30%$98.99M+562,0400.23%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202632771M100.0%62 / 127100 / 4317M7M
Q1 202631168M100.0%68 / 11588 / 3616M6M
Q4 202528361M94.0%61 / 10479 / 428M4M
Q3 202527257M88.5%74 / 9177 / 147M5M
Q2 202521455M85.3%35 / 7779 / 334M3M
Q1 202521454M83.4%35 / 8665 / 246M4M
Q4 202420553M81.6%44 / 7361 / 154M4M
Q3 202417853M82.2%36 / 7542 / 189M6M
Q2 202416154M82.9%25 / 6649 / 357M7M
Q1 202417254M83.3%23 / 6953 / 368M5M
Q4 202318751M79.0%45 / 7051 / 1610M7M
Q3 202315949M75.4%32 / 6831 / 1717M4M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

366 funds held MIRM in Q2 2026, 33% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of MIRMValue% of fundAs of
Vanguard Total Stock Market Index Fund1,648,2102.54%$192.96M0.01%Jun 30, 2026
Strategic Advisers Fidelity U.S. Total Stock Fund1,305,6822.01%$132.53M0.05%May 31, 2026
iShares Russell 2000 ETF1,218,7821.88%$142.68M0.17%Jun 30, 2026
Vanguard Small-Cap Index Fund1,189,1941.83%$139.22M0.07%Jun 30, 2026
SMALLCAP World Fund Inc1,123,0701.73%$131.48M0.14%Jun 30, 2026
State Street(R) SPDR(R) S&P(R) Biotech ETF1,059,2061.63%$124.00M1.16%Jun 30, 2026
T. Rowe Price New Horizons Fund, Inc.823,4541.27%$96.40M0.66%Jun 30, 2026
Janus Henderson Triton Fund791,8741.22%$92.70M1.56%Jun 30, 2026
Eventide Gilead Fund709,1351.09%$83.02M2.41%Jun 30, 2026
Vanguard Small-Cap Growth Index Fund686,3211.06%$80.35M0.17%Jun 30, 2026
Fidelity Small Cap Growth Fund563,9600.87%$59.75M0.68%Jul 31, 2026
Janus Henderson Global Life Sciences Fund558,9930.86%$65.44M1.13%Jun 30, 2026
Vanguard Extended Market Index Fund551,1860.85%$64.53M0.07%Jun 30, 2026
Eventide Healthcare & Life Sciences Fund530,2580.82%$62.08M3.47%Jun 30, 2026
Fidelity Small Cap Index Fund518,8040.80%$54.97M0.16%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Christopher PeetzCHIEF EXECUTIVE OFFICER, Director394,1370.61%Nov 4, 2026
Jolanda HoweSVP, GLOBAL CONTROLLER16,7280.03%Oct 19, 2026
Robert Paul MyersChief Medical Officer550.00%Oct 14, 2026
Eric BjerkholtCHIEF FINANCIAL OFFICER44,7450.07%Sep 15, 2026
Peter RadovichPRESIDENT AND COO57,2600.09%Jun 8, 2026
Joanne QuanCHIEF MEDICAL OFFICER18,8640.03%Mar 17, 2026
Saira RamasastryDirector0–Nov 17, 2026
Laura BregeDirector15,7030.02%Nov 13, 2026
Laurent FischerDirector10,7270.02%Jun 17, 2026
Timothy P. WalbertDirector9,6800.01%Jun 17, 2026
Lon CardonDirector9,6800.01%Jun 17, 2026
William FaireyDirector2,5000.00%Jun 17, 2026
Michael G. GreyDirector330,1600.51%Jun 17, 2026
Patrick J. HeronDirector4,031,6256.21%Jun 17, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Saira Ramasastry
Director
Nov 16, 2026Sale(10b5-1 plan)−2,000$92.28$184.56K0
Saira Ramasastry
Director
Nov 16, 2026Option exercise+2,000$28.97$57.94K2,000
Laura Brege
Director
Nov 11, 2026Sale−3,260$94.74$308.85K15,703
Laura Brege
Director
Nov 11, 2026Sale−10,907$94.05$1.03M18,963
Laura Brege
Director
Nov 11, 2026Option exercise+14,167$16.71$236.73K29,870
Christopher Peetz
CHIEF EXECUTIVE OFFICER, Director
Nov 4, 2026Sale(10b5-1 plan)−20,000$90.00$1.80M206,637
Christopher Peetz
CHIEF EXECUTIVE OFFICER, Director
Nov 4, 2026Option exercise+20,000$2.94$58.72K226,637
Jolanda Howe
SVP, GLOBAL CONTROLLER
Oct 16, 2026Option exercise+16,112$19.24$309.99K16,728
Christopher Peetz
CHIEF EXECUTIVE OFFICER, Director
Oct 6, 2026Option exercise+6,892$15.87$109.38K206,637
Christopher Peetz
CHIEF EXECUTIVE OFFICER, Director
Oct 6, 2026Option exercise+5,305$19.19$101.80K199,745
Eric Bjerkholt
CHIEF FINANCIAL OFFICER
Sep 14, 2026Sale−9,943$98.37$978.09K44,745
Eric Bjerkholt
CHIEF FINANCIAL OFFICER
Sep 11, 2026Option exercise+18,333––54,688
Jolanda Howe
SVP, GLOBAL CONTROLLER
Sep 2, 2026Sale(10b5-1 plan)−658$100.00$65.80K616
Christopher Peetz
CHIEF EXECUTIVE OFFICER, Director
Sep 1, 2026Sale(10b5-1 plan)−21,688$98.91$2.15M194,440
Christopher Peetz
CHIEF EXECUTIVE OFFICER, Director
Sep 1, 2026Option exercise+30,000$2.94$88.20K224,440
Christopher Peetz
CHIEF EXECUTIVE OFFICER, Director
Sep 1, 2026Sale(10b5-1 plan)−8,312$98.08$815.24K216,128
Jolanda Howe
SVP, GLOBAL CONTROLLER
Aug 18, 2026Option exercise+40,000$6.27$250.80K41,274
Jolanda Howe
SVP, GLOBAL CONTROLLER
Aug 18, 2026Sale−40,000$100.00$4.00M1,274
Eric Bjerkholt
CHIEF FINANCIAL OFFICER
Aug 11, 2026Sale(10b5-1 plan)−6,001$99.90$599.50K36,355
Christopher Peetz
CHIEF EXECUTIVE OFFICER, Director
Aug 10, 2026Sale(10b5-1 plan)−2,300$100.14$230.32K194,309
Christopher Peetz
CHIEF EXECUTIVE OFFICER, Director
Aug 10, 2026Sale(10b5-1 plan)−11,683$98.51$1.15M202,626
Christopher Peetz
CHIEF EXECUTIVE OFFICER, Director
Aug 10, 2026Option exercise+20,000$2.94$58.80K214,309
Christopher Peetz
CHIEF EXECUTIVE OFFICER, Director
Aug 10, 2026Sale(10b5-1 plan)−6,017$99.25$597.19K196,609
Jolanda Howe
SVP, GLOBAL CONTROLLER
Aug 3, 2026Sale(10b5-1 plan)−1,840$105.29$193.73K1,274
Eric Bjerkholt
CHIEF FINANCIAL OFFICER
Jul 6, 2026Sale(10b5-1 plan)−3,124$121.67$380.10K44,057
Eric Bjerkholt
CHIEF FINANCIAL OFFICER
Jul 6, 2026Sale(10b5-1 plan)−1,048$122.43$128.31K43,009
Eric Bjerkholt
CHIEF FINANCIAL OFFICER
Jul 6, 2026Sale(10b5-1 plan)−528$123.84$65.39K42,481
Eric Bjerkholt
CHIEF FINANCIAL OFFICER
Jul 6, 2026Sale(10b5-1 plan)−300$124.94$37.48K42,181
Christopher Peetz
CHIEF EXECUTIVE OFFICER, Director
Jul 6, 2026Sale(10b5-1 plan)−1,975$123.74$244.39K196,019
Christopher Peetz
CHIEF EXECUTIVE OFFICER, Director
Jul 6, 2026Sale(10b5-1 plan)−1,710$124.79$213.39K194,309
Christopher Peetz
CHIEF EXECUTIVE OFFICER, Director
Jul 6, 2026Sale(10b5-1 plan)−4,181$122.34$511.50K197,994
Christopher Peetz
CHIEF EXECUTIVE OFFICER, Director
Jul 6, 2026Sale(10b5-1 plan)−12,134$121.65$1.48M202,175
Christopher Peetz
CHIEF EXECUTIVE OFFICER, Director
Jul 6, 2026Option exercise+20,000$2.94$58.80K214,309
Jolanda Howe
SVP, GLOBAL CONTROLLER
Jul 1, 2026Sale(10b5-1 plan)−2,721$120.00$326.52K3,114
Jolanda Howe
SVP, GLOBAL CONTROLLER
Jun 17, 2026Sale(10b5-1 plan)−2,594$101.95$264.46K5,835
Eric Bjerkholt
CHIEF FINANCIAL OFFICER
Jun 9, 2026Option exercise+2,393$26.49$63.39K47,181
Eric Bjerkholt
CHIEF FINANCIAL OFFICER
Jun 8, 2026Sale(10b5-1 plan)−1,567$95.12$149.05K44,788
Eric Bjerkholt
CHIEF FINANCIAL OFFICER
Jun 8, 2026Sale(10b5-1 plan)−2,258$92.84$209.63K47,530
Eric Bjerkholt
CHIEF FINANCIAL OFFICER
Jun 8, 2026Sale(10b5-1 plan)−1,175$93.95$110.39K46,355
Peter Radovich
PRESIDENT AND COO
Jun 5, 2026Option exercise+16,988$19.19$326.00K57,260
Saira Ramasastry
Director
Jun 1, 2026Sale(10b5-1 plan)−3,977$100.00$397.70K0
Christopher Peetz
CHIEF EXECUTIVE OFFICER, Director
Jun 1, 2026Sale(10b5-1 plan)−2,602$94.64$246.25K221,707
Christopher Peetz
CHIEF EXECUTIVE OFFICER, Director
Jun 1, 2026Sale(10b5-1 plan)−16,595$95.34$1.58M205,112
Christopher Peetz
CHIEF EXECUTIVE OFFICER, Director
Jun 1, 2026Sale(10b5-1 plan)−6,926$96.15$665.93K198,186
Christopher Peetz
CHIEF EXECUTIVE OFFICER, Director
Jun 1, 2026Sale(10b5-1 plan)−1,973$97.56$192.49K196,213
Christopher Peetz
CHIEF EXECUTIVE OFFICER, Director
Jun 1, 2026Sale(10b5-1 plan)−1,021$98.20$100.26K195,192
Christopher Peetz
CHIEF EXECUTIVE OFFICER, Director
Jun 1, 2026Sale(10b5-1 plan)−883$99.66$88.00K194,309
Christopher Peetz
CHIEF EXECUTIVE OFFICER, Director
Jun 1, 2026Option exercise+30,000$2.94$88.20K224,309
Saira Ramasastry
Director
May 29, 2026Option exercise+3,977––3,977
Timothy P. Walbert
Director
May 29, 2026Option exercise+3,977––9,680
Lon Cardon
Director
May 29, 2026Option exercise+3,977––9,680
Laurent Fischer
Director
May 29, 2026Option exercise+3,977––10,727
Saira Ramasastry
Director
May 15, 2026Sale(10b5-1 plan)−2,000$109.47$218.94K0
Saira Ramasastry
Director
May 15, 2026Option exercise+2,000$23.51$47.02K2,000
Saira Ramasastry
Director
Apr 15, 2026Option exercise+2,000$23.51$47.02K2,000
Saira Ramasastry
Director
Apr 15, 2026Sale(10b5-1 plan)−2,000$96.90$193.80K0
Saira Ramasastry
Director
Mar 16, 2026Sale(10b5-1 plan)−2,000$90.76$181.52K0
Saira Ramasastry
Director
Mar 16, 2026Option exercise+2,000$23.51$47.02K2,000
Peter Radovich
PRESIDENT AND COO
Mar 16, 2026Sale−16,515$91.98$1.52M40,272
Jolanda Howe
SVP, GLOBAL CONTROLLER
Mar 16, 2026Sale−4,732$91.98$435.25K8,429

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
11.06%
7M shares short
Days to cover
11.8
At 1M shares a day
Change since last report
-2.1%
From 7M shares
Short volume, 20 days
51.2%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Mirum Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 44,759 shares on Sep 22, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Christopher Peetz
Officer, Director
Nov 4, 202620,000$1.80MNov 4, 2026Stock Option Exercise
Joanne Quan
Former Officer
Nov 4, 202614,684$1.42MNov 4, 2026Restricted Stock Units vesting under registered plan
Eric Bjerkholt
Officer
Sep 15, 20269,943$978.09KSep 14, 2026Restricted Stock Units vesting under registered plan
Jolanda Howe
Officer
Sep 2, 2026658$65.80KSep 2, 2026Restricted Stock
Christopher Peetz
Officer, Director
Sep 1, 202630,000$2.96MSep 1, 2026Stock Option Exercise
Jolanda Howe
Officer
Aug 18, 202640,000$4.00MAug 18, 2026Stock Option Exercise
Eric Bjerkholt
Officer
Aug 11, 20266,001$599.51KAug 11, 2026Restricted Stock
Christopher Peetz
Officer, Director
Aug 10, 202620,000$1.98MAug 10, 2026Stock Option Exercise
Jolanda Howe
Officer
Aug 3, 20261,840$193.73KAug 3, 2026Restricted Stock
Eric Bjerkholt
Officer
Jul 6, 20265,000$611.27KJul 6, 2026Restricted Stock
Christopher Peetz
Officer, Director
Jul 6, 202620,000$2.45MJul 6, 2026Stock Option Exercise
Jolanda Howe
Officer
Jul 1, 20262,721$326.52KJul 1, 2026Performance Shares
Jolanda Howe
Officer
Jun 17, 20262,594$264.46KJun 17, 2026Performance Shares
Eric Bjerkholt
Officer
Jun 8, 20265,000$469.07KJun 8, 2026Restricted Stock
Saira Ramasastry
Director
Jun 1, 20263,977$397.70KJun 1, 2026Restricted Stock

See a number that looks wrong?